Brief: EMA Confirms Suicidal Ideation As A Side Effect Of Finasteride 1 And 5 Mg Tablets
08/05/2025 16:11
May 8 (Reuters) - EMA: EMA: CONFIRMED SUICIDAL IDEATION AS A SIDE EFFECT OF FINASTERIDE 1 AND 5 MG TABLETS EMA: PRAC AGREED THAT SUICIDAL IDEATION SHOULD BE INCLUDED AS A SIDE EFFECT OF FINASTERIDE TABLETS EMA: NOT POSSIBLE TO ESTABLISH A LINK BETWEEN SUICIDAL IDEATION AND DUTASTERIDE EMA: NO EVIDENCE LINKING SUICIDAL IDEATION TO FINASTERIDE SKIN SPRAYS Further company coverage: OGN.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary